MRP3 expression did not vary significantly with age (P>0.9999) but showed significant differences with menopausal status, tumor size, histology, clinical stage, lymph node metastasis, PR status, and BRCA2 status. The gene discussed is BRCA2; the disease is metastatic malignant neoplasm in the lymph nodes.